References

Derivation and validation of a chronic total coronary occlusion intervention procedural success score from the 20,000-patient EuroCTO registry: the EuroCTO (CASTLE) score.

10.1016/j.jcin.2018.11.020 · 2019 · External reference

Contemporary issues of percutaneous coronary intervention in heavily calcified chronic total occlusions: an expert review from the European CTO Club.

10.4244/eij-d-22-01096 · 2023 · External reference

Impact of calcium on chronic total occlusion percutaneous coronary interventions.

10.1016/j.amjcard.2017.03.263 · 2017 · External reference

Impact of calcium on the procedural techniques and outcomes of chronic total occlusion percutaneous coronary intervention.

10.1016/j.ijcard.2023.131254 · 2023 · External reference

Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool.

10.1016/j.jcin.2010.09.024 · 2011 · External reference

Predicting periprocedural complications in chronic total occlusion percutaneous coronary intervention: the PROGRESS-CTO complication scores.

10.1016/j.jcin.2022.06.007 · 2022 · External reference

How to treat severely calcified coronary chronic total occlusions.

10.1016/j.jcin.2025.04.043 · 2025 · External reference

Coronary computed tomography angiography to predict successful percutaneous coronary intervention for chronic total occlusion: ready for prime time?

10.1016/j.jcmg.2017.07.014 · 2017 · External reference

Cardiovascular calcification: artificial intelligence and big data accelerate mechanistic discovery.

10.1038/s41569-018-0123-8 · 2019 · External reference

Fibroblast growth factor 21; review on its participation in vascular calcification pathology.

10.1016/j.vph.2019.106636 · 2020 · External reference

Effect of fibroblast growth factor-21 molecule on coronary collateral development.

10.2174/1386207326666221026151525 · 2024 · External reference

Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status.

10.1111/cen.12134 · 2014 · External reference

Elevated serum fibroblast growth factor 21 is associated with hypertension in community-dwelling adults.

10.1038/jhh.2012.52 · 2013 · External reference

High plasma level of fibroblast growth factor 21 is an independent predictor of type 2 diabetes: a 5.4-year population-based prospective study in Chinese subjects.

10.2337/dc11-0294 · 2011 · External reference

Prognostic implication of obstructive sleep apnea diagnosed by post-discharge sleep study in patients presenting with acute coronary syndrome.

10.1016/j.sleep.2014.02.009 · 2014 · External reference

Fibroblast growth factor 21 is an independent predictor of prevalent and incident obstructive sleep apnea.

10.1016/j.isci.2023.105985 · 2023 · External reference

ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography.

10.1016/j.jacc.2006.10.001 · 2007 · External reference

Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study.

10.1016/j.jacc.2005.02.088 · 2005 · External reference

Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology.

10.1093/eurheartj/ehq235 · 2011 · External reference

Development and validation of a novel scoring system for predicting technical success of chronic total occlusion percutaneous coronary interventions: the PROGRESS CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) score.

10.1016/j.jcin.2015.09.022 · 2016 · External reference

Angiographic assessment of collateral connections in comparison with invasively determined collateral function in chronic coronary occlusions.

10.1161/01.cir.0000061953.72662.3a · 2003 · External reference

SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: a report of the society of Cardiovascular Computed Tomography Guidelines Committee: Endorsed by the North American Society for Cardiovascular Imaging (NASCI).

10.1016/j.jcct.2016.10.002 · 2016 · External reference

Quantification of coronary artery calcium using ultrafast computed tomography.

10.1016/0735-1097(90)90282-t · 1990 · External reference

Definitions and clinical trial design principles for coronary artery chronic total occlusion therapies: cto-arc consensus recommendations.

10.1161/circulationaha.120.046754 · 2021 · External reference

Association of spontaneous abortion with all cause and cause specific premature mortality: prospective cohort study.

10.1136/bmj.n530 · 2021 · External reference

Absence of coronary artery calcium identifies asymptomatic diabetic individuals at low near-term but not long-term risk of mortality: a 15-year follow-up study of 9715 patients.

10.1161/circimaging.115.003528 · 2016 · External reference

Coronary artery calcification and its progression: what does it really mean?

10.1016/j.jcmg.2017.10.012 · 2018 · External reference

Coronary chronic total occlusion on coronary CT angiography: what radiologists should know?

10.1186/s13244-024-01621-y · 2024 · External reference

Effect of coronary CTA on chronic total occlusion percutaneous coronary intervention: a randomized trial.

10.1016/j.jcmg.2021.04.013 · 2021 · External reference

A dozen years of discovery: insights into the physiology and pharmacology of FGF21.

10.1016/j.cmet.2019.01.004 · 2019 · External reference

Fibroblast growth factor 21: an emerging pleiotropic regulator of lipid metabolism and the metabolic network.

10.1016/j.gendis.2023.06.033 · 2024 · External reference

The potential function and clinical application of FGF21 in metabolic diseases.

10.3389/fphar.2022.1089214 · 2022 · External reference

Fibroblast growth factor 21 in metabolic syndrome.

10.3389/fendo.2023.1220426 · 2023 · External reference

Insights into the role of FGF21 in coronary heart disease.

10.1016/j.ijbiomac.2024.136911 · 2024 · External reference

Fibroblast growth factor 21 in cardio-metabolic disorders: a systematic review and meta-analysis.

10.1016/j.metabol.2018.01.017 · 2018 · External reference

Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease.

10.1186/1475-2840-12-124 · 2013 · External reference

Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: multi-ethnic study of atherosclerosis.

10.1016/j.atherosclerosis.2019.06.898 · 2019 · External reference

Fibroblast growth factor 21 attenuates calcification of vascular smooth muscle cells in vitro.

10.1111/jphp.12826 · 2017 · External reference

Fibroblast growth factor 21 ameliorates vascular calcification by inhibiting osteogenic transition in vitamin D3 plus nicotine-treated rats.

10.1016/j.bbrc.2017.10.115 · 2018 · External reference

Fibroblast growth factor 21 attenuates vascular calcification by alleviating endoplasmic reticulum stress mediated apoptosis in rats.

10.7150/ijbs.28873 · 2019 · External reference

Fibroblast growth factor 21 inhibits vascular calcification by ameliorating oxidative stress of vascular smooth muscle cells.

10.1016/j.bbrc.2023.01.054 · 2023 · External reference

Fibroblast growth factor 21 predicts and promotes vascular calcification in haemodialysis patients.

10.1159/000512750 · 2021 · External reference

Serum level of fibroblast growth factor 21 predicts long-term prognosis in patients with both diabetes mellitus and coronary artery calcification.

10.21037/apm.2020.03.28 · 2020 · External reference